CGP4540 is primarily utilized in research settings for its role as a selective and potent inhibitor of the enzyme acetylcholinesterase. This property makes it valuable in studies focused on understanding the cholinergic system and its implications in neurological disorders such as Alzheimer's disease. Researchers use CGP4540 to investigate the mechanisms of acetylcholine regulation and to explore potential therapeutic strategies for conditions characterized by cholinergic dysfunction. Additionally, it serves as a tool compound in pharmacological experiments to dissect the roles of acetylcholinesterase in synaptic transmission and cognitive functions. Its application extends to the development of novel treatments targeting neurodegenerative diseases, where modulating acetylcholine levels is critical.